173 related articles for article (PubMed ID: 22411104)
1. Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
Barton MK
CA Cancer J Clin; 2012; 62(3):143-4. PubMed ID: 22411104
[No Abstract] [Full Text] [Related]
2. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.
Burn J; Gerdes AM; Macrae F; Mecklin JP; Moeslein G; Olschwang S; Eccles D; Evans DG; Maher ER; Bertario L; Bisgaard ML; Dunlop MG; Ho JW; Hodgson SV; Lindblom A; Lubinski J; Morrison PJ; Murday V; Ramesar R; Side L; Scott RJ; Thomas HJ; Vasen HF; Barker G; Crawford G; Elliott F; Movahedi M; Pylvanainen K; Wijnen JT; Fodde R; Lynch HT; Mathers JC; Bishop DT;
Lancet; 2011 Dec; 378(9809):2081-7. PubMed ID: 22036019
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and the prevention of colorectal cancer.
Ferrández A; Piazuelo E; Castells A
Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):185-95. PubMed ID: 22542156
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and colorectal cancer prevention in Lynch syndrome.
Chan AT; Lippman SM
Lancet; 2011 Dec; 378(9809):2051-2. PubMed ID: 22036018
[No Abstract] [Full Text] [Related]
6. Aspirin for persons at higher risk for colorectal neoplasia.
Ritt M
J Fam Pract; 2004 Aug; 53(8):637-8; author reply 638. PubMed ID: 15298835
[No Abstract] [Full Text] [Related]
7. Chemoprevention of colorectal neoplasia.
Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
[TBL] [Abstract][Full Text] [Related]
8. [Colorectal cancer chemoprevention].
Starzyńka T; Wasilewicz MP
Pol Merkur Lekarski; 2007 Jul; 23(133):70-3. PubMed ID: 18051834
[TBL] [Abstract][Full Text] [Related]
9. [Chemopreventive agents in colorectal cancer].
Benamouzig R; Chaussade S
Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
[No Abstract] [Full Text] [Related]
10. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
[TBL] [Abstract][Full Text] [Related]
11. Aspirin may help colon cancer patients live longer.
Harv Health Lett; 2013 Jan; 38(3):8. PubMed ID: 23556168
[No Abstract] [Full Text] [Related]
12. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
[TBL] [Abstract][Full Text] [Related]
13. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
Benamouzig R; Uzzan B; Little J; Chaussade S
Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
[TBL] [Abstract][Full Text] [Related]
14. Can aspirin prevent colorectal cancer?
Chan AT
Lancet; 2007 May; 369(9573):1577-8. PubMed ID: 17499581
[No Abstract] [Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
Sangha S; Yao M; Wolfe MM
Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
17. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Burn J; Bishop DT; Mecklin JP; Macrae F; Möslein G; Olschwang S; Bisgaard ML; Ramesar R; Eccles D; Maher ER; Bertario L; Jarvinen HJ; Lindblom A; Evans DG; Lubinski J; Morrison PJ; Ho JW; Vasen HF; Side L; Thomas HJ; Scott RJ; Dunlop M; Barker G; Elliott F; Jass JR; Fodde R; Lynch HT; Mathers JC;
N Engl J Med; 2008 Dec; 359(24):2567-78. PubMed ID: 19073976
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention in Lynch syndrome.
Burn J; Mathers JC; Bishop DT
Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
[TBL] [Abstract][Full Text] [Related]
19. Does aspirin really reduce the risk of colon cancer?
Jankowski J; Barr H; Moayyedi P
Lancet; 2012 Apr; 379(9826):1586-7; author reply 1587. PubMed ID: 22541573
[No Abstract] [Full Text] [Related]
20. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome.
Topping DL; Bird AR; Young GP
N Engl J Med; 2009 Apr; 360(14):1462; author reply 1462-3. PubMed ID: 19348022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
